Bioanalysis of captopril: Two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling
Robbert J. Kok(Utrecht University), Dirk Meijer(University of Groningen), Dick de Zeeuw(University Medical Center Groningen), Frits Moolenaar(University of Groningen), Jan Visser
University of Groningen research database (University of Groningen / Centre for Information Technology)
May 23, 1997
Cited by 4
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k